Kerry Holford

Kerry Holford is a seasoned professional in the field of equity research, with a focus on the pharmaceutical sector. Currently serving as the Head of Global Pharmaceutical Equity Research at Berenberg, Kerry has previously held the position of Head of European Pharmaceutical Equity Research at Exane. Additionally, experience as an Equity Research Analyst was gained at Credit Suisse and Lehman Brothers, contributing to a robust understanding and expertise in pharmaceutical equity analysis.